Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ANTISENSE OLIGONUCLEOTIDES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | ANTISENSE OLIGONUCLEOTIDES |
| Key Genes/Proteins | SNCA |
| Related Pathways | DOPAMINERGIC CELL DYSFUNCTION |
Knowledge base pages for this entity
graph TD
ANTISENSE_OLIGONUCLEOTIDES["ANTISENSE OLIGONUCLEOTIDES"]
ANTISENSE_OLIGONUCLEOTIDES -->|"downregulates"| __SYNUCLEIN["Alpha-SYNUCLEIN"]
ANTISENSE_OLIGONUCLEOTIDES -->|"targets"| mRNA["mRNA"]
ANTISENSE_OLIGONUCLEOTIDES -->|"downregulates"| MALAT1["MALAT1"]
ANTISENSE_OLIGONUCLEOTIDES -->|"inhibits"| Mutant_Gene_Expression["Mutant Gene Expression"]
ANTISENSE_OLIGONUCLEOTIDES -->|"treats"| Neurological_Disorders["Neurological Disorders"]
ANTISENSE_OLIGONUCLEOTIDES -->|"targets"| SOD1["SOD1"]
ANTISENSE_OLIGONUCLEOTIDES -->|"targets"| ATXN2["ATXN2"]
ANTISENSE_OLIGONUCLEOTIDES -->|"inhibits"| Mutant_Protein_Expression["Mutant Protein Expression"]
TFRC["TFRC"] -->|"binds"| ANTISENSE_OLIGONUCLEOTIDES
Tfr1["Tfr1"] -->|"transports"| ANTISENSE_OLIGONUCLEOTIDES
Transferrin_Receptor_1["Transferrin Receptor 1"] -->|"mediates"| ANTISENSE_OLIGONUCLEOTIDES
Oligonucleotide_Transport_Vehi["Oligonucleotide Transport Vehicle"] -->|"modulates"| ANTISENSE_OLIGONUCLEOTIDES| Target | Relation | Type | Str |
|---|---|---|---|
| Mrna | targets | entity | 0.95 |
| MALAT1 | downregulates | gene | 0.95 |
| Α-SYNUCLEIN | downregulates | protein | 0.95 |
| mRNA | targets | entity | 0.95 |
| Cryptic Splicing | inhibits | process | 0.90 |
| Rnase H-Dependent Mrna Degradation | mediates | process | 0.90 |
| Exon Skipping | mediates | process | 0.90 |
| MALAT1 | therapeutic_target | gene | 0.90 |
| SNCA | downregulates | gene | 0.90 |
| GGGGCC Repeat RNA | targets | compound | 0.88 |
| KCNQ2 Mis-splicing | modulates | mechanism | 0.88 |
| Neuronal Hyperexcitability | treats | phenotype | 0.87 |
| ALS | treats | disease | 0.85 |
| Parkinson's Disease | treats | disease | 0.85 |
| Dipeptide Repeat Proteins | downregulates | protein | 0.85 |
| Nucleocytoplasmic Transport Defects | treats | phenotype | 0.85 |
| DOPAMINERGIC CELL DYSFUNCTION | prevents | biological_process | 0.85 |
| Mutant Protein Expression | inhibits | process | 0.85 |
| ATXN2 | targets | gene | 0.85 |
| Neurological Disorders | treats | disease | 0.85 |
| SOD1 | targets | gene | 0.85 |
| C9ORF72 | targets | gene | 0.85 |
| Translation | inhibits | process | 0.85 |
| SOD1 | inhibits | gene | 0.85 |
| Mutant Gene Expression | inhibits | process | 0.85 |
| SRSF1 | targets | protein | 0.80 |
| Alzheimer's Disease | treats | disease | 0.75 |
| Huntington's disease | treats | disease | 0.70 |
| Amyotrophic Lateral Sclerosis | treats | disease | 0.70 |
| Amyotrophic Lateral Sclerosis | treats | disease | 0.70 |
| GGGGCC repeat RNA | inhibits | process | 0.70 |
| Alzheimer'S Disease | treats | disease | 0.70 |
| huntingtin | inhibits | protein | 0.70 |
| gene expression | regulates | process | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Tfr1 | transports | receptor | 0.95 |
| TFRC | mediates | protein | 0.95 |
| TFRC | binds | gene | 0.95 |
| Transferrin Receptor 1 | mediates | receptor | 0.90 |
| transferrin receptor | transports | protein | 0.90 |
| TRANSFERRIN RECEPTOR 1 | associated_with | protein | 0.90 |
| Oligonucleotide Transport Vehicle | modulates | drug | 0.90 |
| Intrathecal Dosing | associated_with | process | 0.80 |
| 37847372 | are therapeutic strategies for | paper | 0.60 |
| CLCN8 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| C1q-Mediated Delivery of miR-33 Antisense Oligonucleotides f | 0.489 | molecular biology | Is APOE4's reduced lipid binding pathoge |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning ANTISENSE OLIGONUCLEOTIDES in their description or question text
No additional research found